Chapter References

1. Hoffman AA: LSD: My Problem Child. Los Angeles, JP Tarcher, 1983.

2. Johnston LD, O'Malley PM, Bachman JG (eds): National Survey Results from the Monitoring the Future Study, 1975-1995. Washington, DC, U.S. Department of Health and Human Services, 1996.

3. Cuomo MJ, Dyment PG, Gammino VM: Increasing use of "ecstasy" (MDMA) and other hallucinogens on a college campus. J Am Coll Health 42:271, 1994

4. Substance Abuse and Mental Health Administration: Year End Preliminary Estimates from the 1996 Drug Abuse Warning Network (DAWN). Washington, DC, US Department of Health and Human Services, 1997.

5. Glennon RA: Do hallucinogens act as 5-HT2 agonists or antagonists? Neuropsychopharmacology 3:509, 1990.

6. Klock JC, Boerner U, Becker CE: Coma, hyperthermia, and bleeding associated with massive LSD overdose: a report of eight cases. Clin Toxicol 8:191, 1975.

7. Abraham HD, Aldridge AM: Adverse consequences of lysergic acid diethylamide. Addiction 88:1327, 1993.

8. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994.

9. Renfroe CL, Messinger TA: Street drug analysis: An eleven year perspective on illicit drug alteration. Semin Adolesc Med 1:247, 1985.

10. Davis M: Mescaline: Excitatory effects on acoustic startle are blocked by serotonin 2 antagonists. Psychopharmacology 93:286, 1987.

11. Johnson MP, Hoffman AJ, Nichols DE: Effects of the enantiomers of MDA, MDMA, and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. Eur J Pharmacol 132:269, 1986.

12. Dowling GP, McDonough ET, Bost RO: 'Eve' and 'ecstasy': A report of five deaths associated with the use of MDEA and MDMA. JAMA 257:1615, 1987.

13. Henry JA, Jeffreys KJ, Dawling S: Toxicity and deaths from 3,4 methylenedioxymethamphetamine ("ecstasy"). Lancet 340:384, 1992.

14. Mueller PD, Korey WS: Death by "ecstasy": the serotonin syndrome? Ann Emerg Med 32:377, 1998.

15. McCann UD, Rideroun A, Shaham Y, et al: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946, 1992.

16. Javitt DC, Zukin SR: Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301, 1991.

17. McCaron MM, Schulze BW, Thompson GA, et al: Acute phencyclidine intoxication: incidence of clinical findings in 1,000 cases. Ann Emerg Med 10:237, 1981.

18. McCarron MM, Schulze BW, Thompson GA, et al: Acute phencyclidine intoxication: clinical patterns, complications, and treatment. Ann Emerg Med 10:290, 1981.

19. Simpson GM, Khajawall AM, Alatorre E et al: Urinary phencyclidine excretion in chronic abusers. J Toxicol Clin Toxicol 19:1051, 1982.

20. Devane WA, Hanus L, Breuer A, et al: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946, 1992.

21. Dackis CA, Pottash ALC, Annitto W, et al: Persistence of urinary marijuana levels after supervised abstinence. Am J Psychiatry 139:1196, 1982.

Dealing With Drugs

Dealing With Drugs

Get All The Support And Guidance You Need To Be A Success At Dealing With Drugs. This Book Is One Of The Most Valuable Resources In The World When It Comes To A Parents Guide To The Drug Talk.

Get My Free Ebook


Post a comment